(S (NP (PRP We)) (VP (VBD discovered) (NP (NP (JJ secular) (NN trend) (NN bias)) (PP (IN in) (NP (NP (DT a) (NN drug) (NN effectiveness) (NN study)) (PP (IN for) (NP (DT a) (ADJP (RB recently) (VBN approved)) (NN drug))))))) (. .))
(S (NP (PRP We)) (VP (VBN compared) (NP (NN treatment) (NNS outcomes)) (PP (IN between) (NP (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT the) (ADJP (RB newly) (VBN approved)) (NN drug)))))) (CC and) (NP (NP (NNS patients)) (VP (VBN exposed) (PP (TO to) (NP (DT the) (JJ standard) (NN treatment)))))))) (. .))
(S (NP (NP (DT All) (NNS patients)) (VP (VBN diagnosed) (PP (IN after) (NP (NP (DT the) (JJ new) (NN drug) (POS 's)) (NN approval) (NN date))))) (VP (VBD were) (VP (VBN considered))) (. .))
(S (NP (PRP We)) (VP (VBD built) (NP (DT a) (NN machine) (VBG learning) (JJ causal) (NN inference) (NN model)) (S (VP (TO to) (VP (VB determine) (NP (NP (NN patient) (NNS subpopulations)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB respond) (ADVP (JJR better)) (PP (TO to) (NP (DT the) (ADJP (RB newly) (VBN approved)) (NN drug)))))))))))) (. .))
(S (PP (IN After) (S (VP (VBG identifying) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ secular) (NN trend) (NN bias))) (PP (IN in) (NP (PRP$ our) (NNS data))))))) (, ,) (NP (PRP we)) (VP (VBD attempted) (S (VP (TO to) (VP (VB adjust) (PP (IN for) (NP (DT the) (NN bias))) (PP (IN in) (NP (CD two) (JJ different) (NNS ways))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBD matched) (NP (NNS patients)) (PP (IN on) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS days))) (PP (IN from) (NP (NP (DT the) (JJ new) (NN drug) (POS 's)) (NN approval) (NN date))) (SBAR (WHADVP (IN that)) (S (NP (NP (NP (DT the) (NN patient) (POS 's)) (NN treatment)) (PRN (-LRB- -LRB-) (ADJP (JJ new) (CC or) (JJ standard)) (-RRB- -RRB-))) (VP (VBD began))))))) (. .))
(S (ADVP (JJ Second)) (, ,) (NP (PRP we)) (VP (VBD included) (NP (DT a) (NN covariate)) (PP (IN in) (NP (DT the) (NN model))) (PP (IN for) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS days))) (PP (IN between) (NP (NP (NP (DT the) (NN date)) (PP (IN of) (NP (NP (NN approval)) (PP (IN of) (NP (DT the) (JJ new) (NN drug)))))) (CC and) (NP (DT the) (NN treatment) (PRN (-LRB- -LRB-) (ADJP (JJ new) (CC or) (JJ standard)) (-RRB- -RRB-)) (NN start) (NN date))))))) (. .))
(S (NP (DT Neither) (NN approach)) (VP (ADVP (RB completely)) (VBD mitigated) (NP (DT the) (NN bias))) (. .))
(S (NP (JJ Residual) (NN bias)) (NP (PRP we)) (VP (VBP attribute) (PP (TO to) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (JJ patient) (NN disease) (NN severity)) (CC or) (NP (JJ other) (JJ unmeasured) (NN patient) (NNS characteristics))))))) (. .))
(S (SBAR (SINV (NNP Had) (NP (PRP we)) (RB not) (VP (VBD identified) (NP (NP (DT the) (JJ secular) (NN trend) (NN bias)) (PP (IN in) (NP (PRP$ our) (NNS data))))))) (, ,) (NP (DT the) (NN causal) (NN inference) (NN model)) (VP (MD would) (VP (VB have) (VP (VBN been) (VP (VBN interpreted) (PP (IN without) (NP (NP (NN consideration)) (PP (IN for) (NP (DT this) (JJ underlying) (NN bias))))))))) (. .))
(S (S (VP (VP (VBG Being) (ADJP (JJ aware) (PP (IN of)))) (, ,) (VP (VBG testing) (PP (IN for))) (, ,) (CC and) (VP (VBG handling)) (NP (NP (JJ potential) (NN bias)) (PP (IN in) (NP (DT the) (NN data)))))) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB diminish) (NP (NP (DT the) (NN uncertainty)) (PP (IN in) (NP (NNP AI) (NN modeling))))))))) (. .))
